UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range

Journal of pharmacological sciences, 2015-03, Vol.127 (3), p.326-331

2015

Volltextzugriff (PDF)

The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets

Behavioural brain research, 2015-07, Vol.287, p.120-126

2015

Volltextzugriff (PDF)

The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone

Behavioural brain research, 2013-05, Vol.244, p.66-69

2013

Volltextzugriff (PDF)

Binding of lurasidone, a novel antipsychotic, to rat 5-HT7 receptor: Analysis by [3H]SB-269970 autoradiography

Progress in neuro-psychopharmacology & biological psychiatry, 2013-01, Vol.40, p.132-137

2013

Volltextzugriff (PDF)

Efficacy of group intervention involving physical activity on subjective well‐being of elderly returnees after evacuation following the Great East Japan Earthquake

Psychogeriatrics, 2019-05, Vol.19 (3), p.246-254

2019

Volltextzugriff (PDF)

Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice

Journal of bioscience and bioengineering, 2008-04, Vol.105 (4), p.395-402

2008

Volltextzugriff (PDF)

The Thoreau Society of Japan Annual Meeting 2019

The Thoreau Society bulletin, 2020-06 (310), p.19-19

Ono, Michiko

2020

Volltextzugriff (PDF)

Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice

Diabetes/metabolism research and reviews, 2002-05, Vol.18 (3), p.185-191

2002

Volltextzugriff (PDF)

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having ( R)-3-amino-3-methyl piperidine as a pharmacophore

Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (24), p.7246-7249

2010

Volltextzugriff (PDF)

The Thoreau Society of Japan Annual Meeting 2018

The Thoreau Society bulletin, 2019-07 (306), p.3-3

Ono, Michiko

2019

Volltextzugriff (PDF)

2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A

Bioorganic & medicinal chemistry, 2011-09, Vol.19 (18), p.5490-5499

2011

Volltextzugriff (PDF)

Thoreau Bicentennial in Japan

The Thoreau Society bulletin, 2017-10 (299), p.11-11

Ono, Michiko

2017

Volltextzugriff (PDF)

Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats

Biological and Pharmaceutical Bulletin, 2009/12/01, Vol.32(12), pp.1991-1996

2009

Volltextzugriff (PDF)

Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice

Metabolism, clinical and experimental, 2000, Vol.49 (1), p.129-133

2000

Volltextzugriff (PDF)

Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: Use of a carboxylate prodrug to improve bioavailability

Bioorganic & medicinal chemistry, 2015-02, Vol.23 (4), p.779-790

2015

Volltextzugriff (PDF)

The anti-fibrotic agent SMP-534 attenuates bleomycin-induced pulmonary fibrosis in hamsters

Biomedical Research, 2009, Vol.30(3), pp.177-182

2009

Volltextzugriff (PDF)

Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain

European neuropsychopharmacology, 2015-10, Vol.25 (10), p.1714-1722

2015

Volltextzugriff (PDF)

Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats

Biological & Pharmaceutical Bulletin, 2009, Vol.32 (12), p.1991-1996

2009

Volltextzugriff (PDF)

Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice

Diabetes (New York, N.Y.), 2000-03, Vol.49 (3), p.436-444

2000

Volltextzugriff (PDF)

The involvement of calmodulin and Ca2+/calmodulin-dependent protein kinase II in the circadian rhythms controlled by the suprachiasmatic nucleus

Neuroscience letters, 1997-05, Vol.227 (1), p.45-48

1997

Volltextzugriff (PDF)

TOLSTOY'S VIEWS ON MAN AND WOMAN IN HIS WORKS AND LIFE

Japanese Slavic and East European Studies, 1988, Vol.9, pp.21-37

ONO, Michiko

1988

Volltextzugriff (PDF)

Chronic administration of SMP-534 ameliorates renal dysfunction in 5/6 nephrectomized rats

Nephron. Experimental nephrology, 2008-01, Vol.110 (4), p.e99-e108

2008

Volltextzugriff (PDF)

Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice

Diabetes (New York, N.Y.), 1999-03, Vol.48 (3), p.588-594

1999

Volltextzugriff (PDF)

2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-diox o-1, 2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluoro b e nzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A

Bioorganic & medicinal chemistry, 2011-09, Vol.19 (18), p.5490-5499

2011

Volltextzugriff (PDF)

Human activities, early farming and natural environment in the north-western Kanto Plain (Central Japan) during the Final Jomon–Early Kofun period (990 cal BCE–330 cal CE) inferred from palynological and archaeobotanical records

Quaternary Environments and Humans, 2024-12, Vol.2 (6), p.100030, Article 100030

2024

Volltextzugriff (PDF)

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Englisch
(330)
Japanisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(196)
Life Sciences & Biomedicine
(172)
Humans
(99)
Male
(84)
Animals
(72)
Female
(65)
Biological And Medical Sciences
(54)
Medical Sciences
(35)
Middle Aged
(35)
Aged
(34)
Mice
(34)
Rats
(28)
Adult
(26)
Pharmacology & Pharmacy
(24)
Fundamental And Applied Biological Sciences. Psychology
(22)
Physical Sciences
(22)
Biochemistry & Molecular Biology
(19)
Chemistry
(17)
Dose-Response Relationship, Drug
(17)
Oncology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range

The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets

The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone

Binding of lurasidone, a novel antipsychotic, to rat 5-HT7 receptor: Analysis by [3H]SB-269970 autoradiography

Efficacy of group intervention involving physical activity on subjective well‐being of elderly returnees after evacuation following the Great East Japan Earthquake

Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice

The Thoreau Society of Japan Annual Meeting 2019

Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having ( R)-3-amino-3-methyl piperidine as a pharmacophore

The Thoreau Society of Japan Annual Meeting 2018

2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A

Thoreau Bicentennial in Japan

Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats

Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice

Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: Use of a carboxylate prodrug to improve bioavailability

The anti-fibrotic agent SMP-534 attenuates bleomycin-induced pulmonary fibrosis in hamsters

Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain

Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats

Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice

The involvement of calmodulin and Ca2+/calmodulin-dependent protein kinase II in the circadian rhythms controlled by the suprachiasmatic nucleus

TOLSTOY'S VIEWS ON MAN AND WOMAN IN HIS WORKS AND LIFE

Chronic administration of SMP-534 ameliorates renal dysfunction in 5/6 nephrectomized rats

Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice

2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-diox o-1, 2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluoro b e nzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A

Human activities, early farming and natural environment in the north-western Kanto Plain (Central Japan) during the Final Jomon–Early Kofun period (990 cal BCE–330 cal CE) inferred from palynological and archaeobotanical records

Suchergebnisse filtern